Report adverse event

Canada

CA

OPEN

ViiV NEWS

Press releases
News updates

Our Media Center contains a range of resources including our latest and archived press releases and news updates, conferences and events we attend, our image and video library and social media information.

- All
- 2020
- 2023
- 2024
- 2025

Showing results for

ViiV Healthcare and the pan-Canadian Pharmaceutical Alliance (pCPA) successfully finalize negotiations for APRETUDE for HIV-1 Pre-Exposure Prophylaxis

17 Feb 2025
ViiV healthcare announces positive data demonstrating 2-drug regimen dovato is as effective as 3-drug regimen biktarvy for maintenance therapy of hiv-1

31 Jul 2024
ViiV Healthcare Announces Health Canada Approval of APRETUDE for PrEP, to reduce the risk of sexually acquired HIV

28 May 2024
Health Canada Grants Priority Review Status of ViiV Healthcare’s New Drug Submission for Cabotegravir Long-Acting Injectable and Tablets for Prevention of HIV

10 Jan 2024
2020
september

Our Media Center contains a range of resources including our latest and archived press releases and news updates, conferences and events we attend, our image and video library and social media information.

Connect with us

ViiV Healthcare ULC
75 Queen Street, suite 1400
Montreal, Quebec H3C 2N6
1-833-737-1257

Report an adverse event

Modern Slavery Statement

NP-CA-HVX-WCNT-230001-E Date: May 2024

©2024 ViiV Healthcare group of companies or its licensor. Trademarks are property of their respective owners.

To report an adverse event or product complaint, please call 1-877-393-8448.